Approval for the taxus express2 paclitaxel-eluting coronary stent system (monorail and over-the-wire).  The device is indicated for improving luminal diameter for the treatment of de novo lesions <28 mm in length in native coronary arteries >= 2.5 to <= 3.75 mm in diameter.